Skip to content
lifestyle.microcapnews.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Humacyte, Inc
Humacyte ATEV Met Superiority Primary Endpoint Compared to Standard of Care AV Fistula in Interim Analysis of V012 Phase 3 Study in Female Dialysis Access Patients
June 10, 2026
Humacyte, Inc. Announces Proposed Public Offering of Common Stock
June 10, 2026
Humacyte Announces Presentation at VASA Meeting of Research Highlighting Self-Repair of ATEV After Cannulation for Dialysis Access
May 26, 2026
Humacyte Announces Symvess® is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs
May 20, 2026
Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update
May 13, 2026
Humacyte Announces New U.S. Department of Defense Funding for Procurement of Bioengineered Blood Vessels
February 12, 2026
←
Previous Page
1
2
3